fb
IMAC Holdings Receives FDA Authorization to Initiate Clinical Study of Its Umbilical Cord-Derived Allogenic Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease

IMAC Holdings Receives FDA Authorization to Initiate Clinical Study of Its Umbilical Cord-Derived Allogenic Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease

BRENTWOOD, Tenn., August 5, 2020 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery...
The Wizard of Wall Street:  Ozzie Smith, IMAC, Nasdaq – and the Fight against Opioids

The Wizard of Wall Street: Ozzie Smith, IMAC, Nasdaq – and the Fight against Opioids

How IMAC partnered with professional athletes to bring chronic pain relief without surgery or opioids to Wall Street.   The story behind IMAC Nation – How did professional athletes get involved? We all love a good documentary, such as a “behind the...

IMAC Expands Reach to Southwest Florida with Purchase of Established Practice in All Cash Transaction

BRENTWOOD, Tenn., January 13, 2020 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today...

IMAC Initiates Sale of BioFirma Subsidiary–IMAC Will Retain Long-Term Supply Agreement at Discount

BRENTWOOD, Tenn., November 12, 2019 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of...